ABSTRACT. Newborn rat brain astrocytes (type 1 astrocytes, 0-2A progenitor cells, and 0-2A progenitor-derived cells, i.e. oligodendrocytes and type 2 astrocytes) were cultivated to investigate the effect of addition of caffeine to the culture medium on glial cell development and secretion of hyaluronan (hyaluronic acid, HA). HA is a glycosaminoglycan, secreted by type 1 astrocytes especially, which is a major component of the extracellular matrix of immature brain involved in morphogenesis and differentiation. Caffeine was added to the culture medium of primary glial cell cultures at concentrations of 102 pM (20 mg/L) or 255 pM (50 mg/L), considered therapeutic and toxic levels, respectively, in human newborns. HA was measured in the culture medium by immunoenzyme assay using sheep brain hyaluronectin, a glycoprotein that exhibits a strong affinity for HA, as probe. In primary glial cell cultures, 102 pM (20 mg/L) caffeine had no visible effect on cell number or on HA secretion. At 255 pM (50 mg/L), there was a significant reduction of cell number (i.e. type 1 astrocytes, 0-2A progenitor cells, and progenitor-derived cells) and a significant increase of HA secretion per cell. These results suggest that caffeine at a high concentration in brain could have a prejudicial effect on the number of proliferating glial cells (astrocytes and oligodendrocytes) and on the composition of the extracellular matrix, which could affect myelination onset.
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Supported by research grants from the Institut National de la Santi et de la Recherche Maicale (CNEP 90 CN 66) and the University of Rouen. caffeine have been suggested (1) and have been found to be free of immediate clinical side effects (4, 5) or short-term neurologic sequelae (6) in the premature infants. Nevertheless, methylxanthines diffuse easily through the blood-brain bamer (7), reduce cerebral blood flow (8-1 l), and increase oxygen consumption in neonates (1 2). They have some potentially deleterious metabolic effects: antagonism of adenosine, a nucleoside involved in many aspects of glial cell and neuron metabolism (13); inhibition of cholesterol synthesis, an important component of the cellular membrane in cultured glial cells (14); and decrease in the activity of cerebroside sulfotransferase, a key enzyme in myelination (1 5).
In immature brain, glial cells are still proliferating and play an important role in the secretion of the ECM macromolecules: laminin, fibronectin (1 6, 17), and glycosaminoglycans (1 8, 19) . HA is one of these glycosaminoglycans, and it has an important role in the developing brain. It is a natural substrate upon which cells migrate and proliferate in vivo. Subsequent differentiation is accompanied by a decrease of HA level in the ECM (1 9).
The purpose of our study was to investigate the effects of caffeine on glial development and HA secretion in newborn rat brain glial cell cultures. The affinity of HN, a brain HA-binding glycoprotein (20), was used for the quantification of HA secretion in the medium.
MATERIAL AND METHODS
Materials. Female Wistar rats were housed in groups and fed laboratory rat food and water ad libitum in the Centre Henri Becquerel facilities.
MEM with a-ribonucleosides and HBSS (lox) were obtained from GIBCO (Cergy-Pontoise, France). FCS, HBSS ( l x ) with (+) and without (-) calcium and magnesium salts, and trypsin ( l x ) were purchased from Eurobio (Paris, France); BSA from Sigma (la Verpiliire, France), Superose 6 column for HPLC from Pharmacia (les Ulis, France), and HA from Fluka (Mulhouse, France). Antiserum to sheep HN was raised in rabbits, and sheep brain HN was purified as described previously (21, 22) . Monoclonal anti-GFAP antibody was purified in the laboratory (23). Mouse monoclonal A2B5 was obtained from the American Type Culture Collection (Rockville, MD). Rabbit polyclonal antigalactocerebroside antibody (anti-Galc) was kindly donated by Dr. Hiroaki Asou (Tokyo, Japan) and by Dr. Bernard Zalc (Paris, France). Goat polyclonal antihuman von Willebrand factor was from Biorad (Ivry-sur-Seine, France), and mouse monoclonal anti-type 3 complement receptor IgG2 A (OX-42) was from Serotec (Paris, France , and tissue culture flasks and plates were from Falcon (Poly Labo Paul Block). Caffeine (1 mL = 10 mg) was purchased from Meram (Paris, France). The kit for caffeine immunoassay was from Syva Company (Lyon, France).
Methods. Primary glial cell cultures. Primary glial cell cultures were established using the method of MacCarthy and de Vellis (24). Three male or female pups of one litter were killed by decapitation within a few hours after birth. Both hemispheres were removed from one cerebrum. Meninges were dissected off to avoid dural and meningeal contamination in HBSS (+) at room temperature. Brain cells were dissociated mechanically with a syringe and a 2-mm diameter needle in MEM and allowed to settle for 5 min at room temperature. The supernatant was discarded, and the pellet was resuspended in MEM and redissociated twice. Supernatants were pooled and centrifuged (800 rpm, 10 min, 4'C). Cells were counted on a hemocytometer and plated in 12-well plates at a density of 7.5 x lo5 cells/mL. Cultures were maintained in a humidified incubator at 37°C gassed with 5% C02. Medium was changed every 3 d.
Caffeine. All the cultures were done in standard conditions as described above and in medium supplemented with caffeine. Because in vivo it diffuses integrally through the blood-brain bamer (7), caffeine was added to obtain a concentration of 102 pM (20 mg/L) or 255 pM (50 mg/L), which are considered therapeutic and toxic levels, respectively, in the human newborn (1). Caffeine was added to MEM every 3 d when MEM was changed. Caffeine concentration in medium was measured with the immunoenzyme assay.
Immunostainings. Immunostainings were performed to recognize the different cell types of glial lineage (25). To detect GFAP, cultures were fixed in acetone for 10 rnin and labeled with a monoclonal anti-GFAP antibody (undiluted supernatant). Fluorescein-conjugated second antibody (1:20) was used. To detect A2B5 and Galc antigens, cultures were fixed in 2.5% .pformaldehyde in PBS for 8-10 rnin and were incubated wth A2B5 antibody (1: 10) or anti-Galc antibody (1: 10) for 30 min. Texas red-conjugated second antibody (1:30) was used after A2B5 antibody, and fluorescein-conjugated second antibody (1:20) after anti-Galc antibody.
Coverslips were mounted on slides and observed with a microscope equipped with epifluorescence objectives (Leitz). Glial phenotypes in primary glial cell cultures were defined as follows: 1 ) large, flat cell without visible cell process in confluent cultures, A2B5 (-), GFAP (+): type 1 astrocyte; 2) small-size cell with fine cell processes and dark body resting on the top of a bed layer of type 1 astrocytes, A2B5 (+), GFAP (-): 0-2A progenitor cell; 3) small cell with long processes A2B5 (+), GFAP (+): type-2 astrocyte; and 4) small stellate cell with a refringent body and numerous very fine processes, Galc (+): oligodendrocyte. Immunostainings were performed also to recognize endothelial cells and microglial cells. The rare occurrence of microglial cells and the absence of endothelial cells were detected with OX-42 (1 : 100) and with antihuman von Willebrand factor (1:80), respectively.
HA immunoenzyme assay. Supernatant HA concentration was determined by the indirect immunoassay using sheep brain HN (2 1,22). HN is a glycoprotein extracted from brain that binds to HA but not to other glycosaminoglycans (20) and can be used as a probe for a quantitative estimation of HA. Plastic microtest plates with 96 wells were coated with a 100 mg/L HA in 0.1 M bicarbonate with 0.2 g/L sodium azide. Samples of culture medium were preincubated during 1 h in a test tube with a 30-pg/L sheep brain HN solution. Samples were incubated on HAcoated microtest plates for 4 h. Maximum sensitivity was achieved when incubation was canied out at 4°C. HN bound to the plate was revealed after a 1-h incubation with immune complexes obtained by mixing anti-sheep HN IgG (1:2000) and alkaline phosphatase-conjugated donkey anti-rabbit globulin antibodies (1:5000) in PBS with 0.2 g/L sodium azide and 1 g/L BSA. The phosphatase substrate was para-nitrophenyl phosphate (1 g/L in 1 M diethanolamine equilibrated at pH 9.8 by concentrated HCI and containing 0.00 1 M MgCI2). After a I -h incubation with substrate at 37"C, absorbance variations, a function of HA concentration, were recorded on a Titertek Multiskan instrument (Flow, Paris, France) at 405 nm. The test is specific and could detect 1 pg/L HA. Specificity of the assay was verified by Streptomyces hyaluronidase digestion of sample. Recovery of HA was good and intra-and interassay variation coefficients were 6 f 2.2 and 12%, respectively. Comparison of six assays, developed in different laboratories, including ours, was done and showed results of the same magnitude (26).
A 10% FCS medium was used as control. For each sample, the HA concentration of the control was deducted from the HA concentration of the medium sample to obtain HA secretion. According to our previous results in cultures enriched by passage either in type 1 astrocytes or in total 0-?A lineage cells (27, 28) , it has been demonstrated that HA was secreted into the medium by type 1 astrocytes but not by 0-2A progenitor and 0-2A progenitor-derived cells. Because type 1 astrocytes are by far the largest population of cells in primary glial cell cultures (95%), we divided the HA sample concentration by the total glial cell number present in the corresponding well to have a secretion of HA per hour and per cell.
Cell counting. Upper small cells (i.e. 0-2A progenitor and 0-2A progenitor-derived cells) present on the surface of the bottom bed layer of type 1 astrocytes in the cultures were counted on the phase contrast microscope, which was equipped with an ocular micrometer. Nine fields of 0.3 mm2 were counted in each well. Thereafter, medium was drawn off from wells. Cultures were rinsed with HBSS (-) for 15 rnin ( 1 mL/well) and trypsinized for 8 rnin (0.5 mL/well). Cells were aspirated with a syringe and trypsinization was stopped by addition of MEM with 10% FCS (2 mL/well). All glial cells (i.e. type 1 astrocytes, 0-2A progenitor and 0-2A progenitor-derived cells) were counted on a hemocytometer.
HPLC. To characterize HA molecular size, HPLC was run in PBS through a Superose 6 column driven by Beckman equipment.
Statistics. A two-way analysis of variance was used to evaluate cell number or HA secretion as a function of time or phases of culture; when a significance was determined ( p < 0.05), Newman Keuls test was performed post hoc to identify significant differences between means. Log values were used for statistical calculations. Measurements are reported as means & SD.
RESULTS
Efect of caffeine on glial cell number (Fig. I) . In primary glial cell cultures, caffeine added into the medium at 102 pM (20 mg/ L) had no effect on cell number: neither type 1 astrocytes nor 0-2A progenitor or 0-2A progenitor-derived cell numbers were altered compared with controls. In phase-contrast microscopy, there was no difference between cultures in control medium and cultures in medium with caffeine at 102 pm (20 mg/L). Flat GFAP (+) type 1 astrocyte were confluent between d 6 and 9 and A2B5 (+) 0-2A progenitor or 0-2A progenitor-derived cells were numerous on the top of the bed layer between d 8 and 10. Caffeine at the concentration of 255 pM (50 mg/L) decreased the cell numbers. According to microscopic observation, confluence was obtained later (around d 12 and 15 instead of d 6 and 9 in control cultures). At the end of the experiments (d 18), the total number of glial cells (i.e. type 1 astrocytes, 0-2A progenitor cells, and 0-2A progenitor-derived cells) was lower (30%) in cultures with caffeine at 255 pM (50 mg/L) than in control cultures or in cultures with caffeine at 102 pM (20 mg/L) (30%)
